Product Description
Adrim 50mg Injection 25ml is a hot-selling, world-class oncology solution, formulated with pegylated liposomal Doxorubicin Hydrochloride (50mg/25ml, 2mg/ml). This formidable product features a clear vial label and prime liquid formulation, ideal for intravenous administration. Packaged in a 25ml vial adhering to IP pharmacopoeia standards, Adrim is designed exclusively for oncologist prescription in hospital settings. With stringent refrigerated storage requirements (2-8C) and a robust 24-month shelf life, it is the featured choice for cancer therapy both domestically and across export markets. Procure from top Indian manufacturers, suppliers, and exporters today.
Prime Oncology Solution With Advanced Features
Adrim 50mg Injection 25ml is engineered for oncology and hospital use, featuring a robust pegylated liposomal formulation. Its prescription-only status ensures safe administration by specialists. The clear-labeled vial contains a likely red liquid, providing a dependable visual cue for users. The product stands out in oncology with a formidable application mechanism, streamlined intravenously for effective chemotherapy. As an exporter, manufacturer, and supplier, Adrim upholds top-tier standards to meet the needs of healthcare professionals globally.
Outlay, Export Markets & Secure Packaging
Adrim 50mg Injection 25ml is delivered swiftly thanks to a streamlined logistics outlay suited for both domestic and export markets. The product is securely packaged in clear 25ml vials to maintain efficacy and stability during transit. With a prime focus on major export markets and reliable domestic distribution, suppliers ensure that Adrim consistently reaches hospital pharmacies intact and on time. Each vial is handled with care to uphold the pharmacopoeia standard and product integrity.
FAQ's of Adrim 50mg Injection 25ml:
Q: How is Adrim 50mg Injection 25ml administered?
A: Adrim 50mg Injection 25ml is administered intravenously under the supervision of an oncologist or medical professional, ensuring precise dosage and safety during cancer chemotherapy treatment.
Q: What makes Adrim 50mg Injection 25ml a featured product for cancer treatment?
A: The product utilizes a pegylated liposomal formulation of Doxorubicin Hydrochloride, delivering potent, targeted chemotherapy while enhancing drug stability and reducing common side effects.
Q: When should Adrim 50mg Injection 25ml be stored in a refrigerator?
A: Adrim 50mg Injection 25ml should be stored immediately at a temperature between 2C and 8C upon receipt to preserve its effectiveness and ensure compliance with recommended storage instructions.
Q: Where is Adrim 50mg Injection 25ml primarily supplied?
A: Adrim 50mg Injection 25ml is supplied to hospitals, oncology clinics, and institutional healthcare providers both domestically and through export markets, serving healthcare needs in India and abroad.
Q: What is the process for procuring Adrim 50mg Injection 25ml as a hospital pharmacy?
A: Hospitals and institutional buyers can procure Adrim by contacting accredited manufacturers, exporters, or suppliers in India, following standard medical procurement procedures and prescription requirements.
Q: What are the primary benefits of using Adrim 50mg Injection 25ml in cancer therapy?
A: Adrim offers reliable, world-class efficacy in chemotherapy, featuring a prime, stable formulation with increased therapeutic performance and a 24-month shelf life-making it a formidable option against cancer.
Send Inquiry
Send Inquiry
Send SMS
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese